Plain-English answer
The Annotated Bibliography for U.S.-China Healthcare supports comparison and cross-border pages by combining system-level sources, regulatory sources, payer and reimbursement sources, market-entry evidence, data governance materials, and business diligence.
How to use this reference
Editorial method and evidence use: Annotated Bibliography for U.S.-China Healthcare is a practical editorial reference, not a market thesis. The Annotated Bibliography for U.S.-China Healthcare supports comparison and cross-border pages by combining system-level sources, regulatory sources, payer and reimbursement sources, market-entry evidence, data governance materials, and business diligence. The page’s primary lens is source set for comparison and cross-border pages. Avoidable error: Comparing countries by ideology instead of decision mechanisms.
Concretely, use this page to decide what kind of evidence a claim needs: official policy text, administrative data, peer-reviewed research, field evidence, historical context, or strategic inference. The aim is disciplined judgment: enough sourcing to make the reasoning transparent, without turning every explanatory page into a citation ledger.
How this page should be used
These methods pages explain the editorial standards behind source selection, evidence grading, terminology, Chinese-language access, and preservation of historical material.
Operating mechanism
Cross-border analysis needs both sides of the comparison. A U.S. product pathway cannot be understood only through FDA, and a China pathway cannot be understood only through NMPA.
Decision rule
Use this source set when comparing systems, developing entry strategy, evaluating market access, writing bilingual explainers, or assessing U.S.-China product commercialization.
Evidence and source logic
The best cross-border pages distinguish regulatory permission, payment, procurement, evidence, data governance, commercial channel, and institutional trust.
Core sections
U.S. official sources
FDA, CMS, HHS, ONC, Census, CDC, state Medicaid, and payer medical policies.
China official sources
NHC, NHSA, NMPA, State Council, China CDC, provincial agencies, and local procurement sources.
Comparative health system sources
WHO, OECD, peer-reviewed comparative policy, and health economics literature.
Commercial diligence sources
Interviews, tender records, coverage policies, hospital purchasing materials, partner documents, and investor diligence.
Implementation checklist
| Check | Reason | Failure mode |
|---|---|---|
| Does the page have a clear parent hub? | Readers need a clear path from broad hubs to specific topics. | Orphan pages that crawlers and readers cannot interpret. |
| Does the source family match the claim? | Regulatory, data, clinical, and strategy claims require different sources. | Overconfident pages built on weak source fit. |
| Does the page avoid public date-label clutter? | Current content should not be made artificially stale. | Stable explanations that look obsolete because of visible metadata. |
Method pitfall
Comparing countries by ideology instead of decision mechanisms. A stronger approach is to connect content structure, source logic, and internal links before expanding page count.